The cluster is small and lacks insider corroboration, suggesting limited conviction. Monitor next quarter's 13F for follow-through and watch for any insider buying or pipeline catalysts that could shift the narrative.
CTNM drugs
CTNM drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $10.56entry
- T+1 · 6d ago +1.99%α +0.67% · $10.77
- T+4 · todayOpen
- T+5 · in 3h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Four asset managers added to their CTNM positions in Q3 2026, totaling $577K in net buying, while one seller trimmed $750K. The cluster is small in dollar terms and dominated by passive/index-oriented managers, with no insider buying corroboration. The moves follow a wider Q3 net loss reported a week earlier, but the buying may reflect long-term positioning on the company's cash runway and pipeline progress.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$173.0K
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Alps Advisors | ADD | +30.6% | $582.0K | $38.0K |
| Dimensional Fund Advisors | ADD | +36.8% | $3.3M | $349.0K |
| Us Bancorp \de | ADD | +54.5% | $3.0K | $534.00 |
| Nuveen | ADD | +61.7% | $775.0K | $190.0K |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Barclays | TRIM | -73.9% | $953.0K | -$750.0K |
Key Facts
- 4 asset managers added CTNM positions in Q3 2026, net buying $577K
- 1 seller (Barclays) trimmed $750K, making net cluster flow slightly negative (-$173K)
- Dimensional Fund Advisors added the most value (+$349K, 36.8% increase)
- Nuveen added +61.7% shares, the largest percentage increase among buyers
- Insider buying confluence score is 3/100, with zero open-market insider buys
- Q3 2026 net loss of $18.7M was wider than the $12.8M loss in Q3 2025
Financial Impact
4 institutions accumulated $577K in new CTNM positions while 1 reduced holdings by $750K, for a net negative flow of $173K
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- No insider buying to confirm institutional thesis
- Wider net loss in Q3 2026 could pressure sentiment if cash burn accelerates
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CTNM-2026-Q3 |
Track record
14 reports on CTNM
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $9.72 settles Dec 15
- Nov 10, 20266d ago Institutional Cluster Neutral 2/10 Viewing Entry $10.56 settles Dec 9
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $9.52 settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $8.81 settles Dec 4
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $8.81 settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 3/10 Entry $9.79 settles Dec 3
- Oct 28, 202619d ago SC 13G Neutral 3/10 Entry $9.33 settles Nov 27
- Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $9.15 settles Nov 25
- Oct 22, 202625d ago SC 13G Neutral 3/10 Entry $8.31 settles Nov 20
- Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $13.40 to $8.46 ▼ −36.87% −36.31% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers